# US 2015/0147432 A1 · Stable thickener formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147432 A1
- Document ID: US20150147432A1
- Status: Published application
- Kind: A1
- Application number: 14/612,847
- Filed: 2015-02-03
- Published: 2015-05-28
- Earliest claimed: 2009-10-26
- Assignees: Nestec S.A.
- Applicants: Nestec S.A.
- Inventors: Erin Olson
- Web page: https://patentgrep.com/patent/US20150147432A1

## CPC

- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A23L 29/212: Starch; Modified starch; Starch derivatives, e.g. esters or ethers (containing starch hydrolysates, e.g. dextrin, A23L29/30)
- A23L 29/219: Chemically modified starch; Reaction or complexation products of starch with other chemicals
- A23L 29/256: from seaweeds, e.g. alginates, agar or carrageenan
- A23L 29/27: {Xanthan not combined with other microbial gums}
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/12: of the kidneys
- A61P 25/26: Psychostimulants, e.g. nicotine, cocaine
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Stable thickener formulations and nutritional compositions having the stable thickener formulations are provided. In a general embodiment the present disclosure provides a stable thickener formulation comprising from about 0.015% to about 0.05% by weight of carrageenan and from about 1.2% to about 4.0% by weight of starch. The stable thickener formulation can be used in nutritional compositions used to treat a variety of physiological conditions.

## Claims

### Claim 1

A method for treating a medical condition in a patient, the method comprising administering to the patient a composition including a stable thickener formulation selected from the group of:
from about 0.03% to about 0.05% by weight of carrageenan and from about 1.5% to about 4.0% by weight of starch, and at least one nutritional ingredient, the viscosity of the formulation is from about 300 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof;
a weight of carrageenan and a weight of starch in a ratio of about 1:69 to about 1:122, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 300 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof;
about 0.1% to about 0.14% by weight of xanthan gum and from about 2.5% to about 2.7% by weight of starch, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 1100 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof; and
a weight of xanthan gum and a weight of starch in a ratio of about 1:18 to about 1:27, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 1100 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof.

### Claim 2 (depends on 1)

The method of claim 1, wherein the medical condition is selected from the group consisting of dysphagia, renal failure, chronic obstructive pulmonary disorders, malabsorption disorders, post-stroke, and combinations thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the medical condition is dysphagia.

### Claim 4 (depends on 1)

The method of claim 1, wherein the medical condition is renal failure.

### Claim 5 (depends on 1)

The method of claim 1, wherein the medical condition is a chronic obstructive pulmonary disorder.

### Claim 6 (depends on 1)

The method of claim 1, wherein the medical condition is a malabsorption disorder.

### Claim 7 (depends on 1)

The method of claim 1, wherein the medical condition is post-stroke.

### Claim 8 (depends on 1)

The method of claim 1, wherein the patient is an elderly person.

### Claim 9

A method for providing nutrition to a patient with dysphagia comprising administering to the patient a composition including a stable thickener formulation selected from the group consisting of:
from about 0.03% to about 0.05% by weight of carrageenan and from about 1.5% to about 4.0% by weight of starch, and at least one nutritional ingredient, the viscosity of the formulation is from about 300 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof;
a weight of carrageenan and a weight of starch in a ratio of about 1:69 to about 1:122, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 300 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof;
about 0.1% to about 0.14% by weight of xanthan gum and from about 2.5% to about 2.7% by weight of starch, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 1100 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof; and
a weight of xanthan gum and a weight of starch in a ratio of about 1:18 to about 1:27, and at least one nutritional ingredient, wherein the viscosity of the formulation is from about 1100 cps to about 9000 cps, and wherein the nutritional ingredient comprises at least one ingredient selected from the group consisting of a carbohydrate, a protein, a fat, prebiotics, probiotics, symbiotics, fish oils, phytonutrients, antioxidants, vitamins, minerals and combinations thereof.

### Claim 10 (depends on 9)

The method of claim 9, wherein the patient has a medical condition.

### Claim 11 (depends on 10)

The method of claim 10, wherein the medical condition is selected from the group consisting of renal failure, chronic obstructive pulmonary disorders, malabsorption disorders, post-stroke, and combinations thereof.

### Claim 12 (depends on 10)

The method of claim 10, wherein the medical condition is renal failure.

### Claim 13 (depends on 10)

The method of claim 10, wherein the medical condition is a chronic obstructive pulmonary disorder.

### Claim 14 (depends on 10)

The method of claim 10, wherein the medical condition is a malabsorption disorder.

### Claim 15 (depends on 10)

The method of claim 10, wherein the medical condition is post-stroke.

### Claim 16 (depends on 9)

The method of claim 9, wherein the patient is an elderly person.
